Aminologics Co.,Ltd. (KOSDAQ:074430)

Aminologics Statistics

Total Valuation

Aminologics has a market cap or net worth of KRW 87.65 billion. The enterprise value is 57.66 billion.

Market Cap	87.65B
Enterprise Value	57.66B

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Aminologics has 87.83 million shares outstanding.

Current Share Class	87.83M
Shares Outstanding	87.83M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	0.17%
Float	59.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.51
PB Ratio	1.60
P/TBV Ratio	1.69
P/FCF Ratio	13.59
P/OCF Ratio	12.59
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-61.20
EV / Sales	3.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	8.94

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.28.

Current Ratio	2.54
Quick Ratio	2.25
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	2.38
Interest Coverage	-22.07

Financial Efficiency

Return on equity (ROE) is -1.70% and return on invested capital (ROIC) is -1.74%.

Return on Equity (ROE)	-1.70%
Return on Assets (ROA)	-1.51%
Return on Invested Capital (ROIC)	-1.74%
Return on Capital Employed (ROCE)	-3.23%
Revenue Per Employee	397.62M
Profits Per Employee	-23.55M
Employee Count	40
Asset Turnover	0.22
Inventory Turnover	1.70

Taxes

In the past 12 months, Aminologics has paid 329.59 million in taxes.

Income Tax	329.59M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.22% in the last 52 weeks. The beta is 0.82, so Aminologics's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	-12.22%
50-Day Moving Average	1,071.90
200-Day Moving Average	979.71
Relative Strength Index (RSI)	39.99
Average Volume (20 Days)	107,927

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aminologics had revenue of KRW 15.90 billion and -942.08 million in losses. Loss per share was -10.73.

Revenue	15.90B
Gross Profit	3.95B
Operating Income	-1.79B
Pretax Income	-612.49M
Net Income	-942.08M
EBITDA	-1.30B
EBIT	-1.79B
Loss Per Share	-10.73

Balance Sheet

The company has 45.37 billion in cash and 15.38 billion in debt, giving a net cash position of 29.99 billion or 341.51 per share.

Cash & Cash Equivalents	45.37B
Total Debt	15.38B
Net Cash	29.99B
Net Cash Per Share	341.51
Equity (Book Value)	54.82B
Book Value Per Share	624.17
Working Capital	48.39B

Cash Flow

In the last 12 months, operating cash flow was 6.96 billion and capital expenditures -509.00 million, giving a free cash flow of 6.45 billion.

Operating Cash Flow	6.96B
Capital Expenditures	-509.00M
Free Cash Flow	6.45B
FCF Per Share	73.46

Margins

Gross margin is 24.86%, with operating and profit margins of -11.26% and -5.92%.

Gross Margin	24.86%
Operating Margin	-11.26%
Pretax Margin	-3.85%
Profit Margin	-5.92%
EBITDA Margin	-8.16%
EBIT Margin	-11.26%
FCF Margin	40.56%

Dividends & Yields

Aminologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.07%
FCF Yield	7.36%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2009. It was a forward split with a ratio of 5.

Last Split Date	Oct 23, 2009
Split Type	Forward
Split Ratio	5

Scores

Aminologics has an Altman Z-Score of 1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.38
Piotroski F-Score	2